Enzo Biochem Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	20.29	-18.26	7.88	-28.52	2.49	Upgrade
Depreciation & Amortization	2.68	2.83	2.65	2.78	3.04	Upgrade
Share-Based Compensation	3.15	2.34	1.64	1.77	1.79	Upgrade
Other Operating Activities	-63.09	-3.5	-11.78	6.79	-2.51	Upgrade
Operating Cash Flow	-36.98	-16.59	0.39	-17.18	4.81	Upgrade
Capital Expenditures	-2.76	-3.47	-4.44	-2.17	-8.13	Upgrade
Acquisitions	101.74	0	0	0	0	Upgrade
Change in Investments	0	28.7	-30.06	0	0	Upgrade
Investing Cash Flow	98.98	25.22	-34.5	-2.17	-8.13	Upgrade
Share Issuance / Repurchase	0.4	0.03	0.1	0	0.17	Upgrade
Debt Issued / Paid	-1.53	-0.27	-0.34	7	4.03	Upgrade
Financing Cash Flow	-1.13	-0.24	-0.24	7	4.19	Upgrade
Exchange Rate Effect	-0.11	-0.06	0.01	0.07	-0.02	Upgrade
Net Cash Flow	60.77	8.33	-34.34	-12.28	0.86	Upgrade
Free Cash Flow	-39.74	-20.06	-4.05	-19.35	-3.32	Upgrade
Free Cash Flow Margin	-127.93%	-61.46%	-3.44%	-25.45%	-4.09%	Upgrade
Free Cash Flow Per Share	-0.81	-0.41	-0.08	-0.41	-0.07	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).